Clinical Trial: Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional



Official Title: A Phase I Dose Escalation Study of VS-4718, A Focal Adhesion Kinase Inhibitor, In Subjects With Relapsed or Refractory Acute Myeloid Leukemia or B-Cell Acute Lymphoblastic Leukem

Brief Summary:

The main purpose of this study is to test the safety and efficacy of VS-4718 in two types of leukemia patients and to find the right dose of VS-4718 for future clinical trials.

Other purposes of this study include:

  • Testing for study drug VS-4718 levels in blood over time and what happens to the study drug in patients.
  • To find out if there are certain biomarkers in leukemia patients that predict if and how 4718 study drug may or may not work.